Related Experiment Video
Updated: Sep 30, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Nevirapine (Viramune) strengthens warning on liver, skin toxicities
Abstract:
A recent letter to doctors strengthened the U.S. warnings and precautions on using this antiretroviral (which has been approved and in widespread use for years), due to serious complications in a small minority of patients; the point of the changes is to catch such problems and stop the drug in time. Patients obtaining refills or new prescriptions should in the future receive a "patient package insert," dated November 2000, based on the new warnings.
Related Concept Videos
Drug Toxicity: Risk factors
Antiviral Nucleoside Inhibitors
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug Toxicity: Overview
Drug Toxicity: Allergic Reactions
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
